Ad image

Uncategorized

Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market

Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance…

NFL wants a cut of private equity investment profits as vote looms

NFL owners are planning to vote on a proposal Tuesday that would allow private equity firms to take a maximum…

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

The success of Eli Lilly's weight loss and diabetes drugs Zepbound and Mounjaro caused the company to hike its guidance.

- Advertisement -
Ad imageAd image
TODAYNEO